Subscribe Login
DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5
A-Brands

J&J Starts Share Exchange Offer For Consumer Health Spin-Off Kenvue

By Reuters
Share this article
J&J Starts Share Exchange Offer For Consumer Health Spin-Off Kenvue

Johnson & Johnson has announced the launch of an exchange offer under which its stockholders can opt for shares of Kenvue, its newly listed consumer health unit.

J&J, which currently owns an 89.6% stake in Kenvue, said it intends to split off at least 80.1% of the consumer health company's shares as part of the offering.

The offering will help J&J move a step closer in its plan to spin off the unit and focus on its larger medical devices and pharmaceuticals businesses.

The exchange will allow J&J shareholders to exchange their shares for those of Kenvue at a 7% discount, subject to conditions.

“The separation of Kenvue further sharpens Johnson & Johnson’s focus on transformational innovation specifically in Pharmaceutical and MedTech,” said Joaquin Duato, chairman and chief executive officer of Johnson & Johnson.

ADVERTISEMENT

“We believe now is the right time to distribute our Kenvue shares, and we are confident that a split-off is the appropriate path forward to bring value to our shareholders.”

Kenvue, has forecast full-year profit above Wall Street estimates, betting on resilient demand for its skincare and self-care products, such as Neutrogena and Tylenol.

Kenvue

Kenvue, which debuted on the New York Stock Exchange in May, has a market capitalisation of about $46 billion (€41.5 billion).

The offering comes days after J&J and Kenvue both forecast strong profit for this year.

ADVERTISEMENT

‍Goldman Sachs and J.P. Morgan Securities are serving as dealer managers for the offering, J&J said.

J&J shares rose about 1% in premarket trading.

Article by Reuters, additional reporting by ESM

Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.